Quest Diagnostics Incorporated (BMV:DGX)

Quest Diagnostics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	992	871	854	946	1,995
Depreciation & Amortization	570	493	439	437	408
Loss (Gain) From Sale of Investments	-	-	-	-	-314
Stock-Based Compensation	88	88	77	77	79
Provision & Write-off of Bad Debts	3	5	1	3	4
Other Operating Activities	183	78	46	136	-26
Change in Accounts Receivable	-106	-71	-15	246	81
Change in Accounts Payable	129	-67	-55	-149	35
Change in Income Taxes	24	16	-2	-31	-20
Change in Other Net Operating Assets	3	-79	-73	53	-9
Operating Cash Flow	1,886	1,334	1,272	1,718	2,233
Operating Cash Flow Growth	41.38%	4.87%	-25.96%	-23.06%	11.37%
Capital Expenditures	-527	-425	-408	-404	-403
Cash Acquisitions	-101	-2,164	-611	-144	-331
Investment in Securities	-	-	-	-	755
Other Investing Activities	-3	41	-42	5	-
Investing Cash Flow	-631	-2,548	-1,061	-543	21
Long-Term Debt Issued	410	1,846	2,592	-	-
Long-Term Debt Repaid	-1,012	-303	-1,844	-2	-2
Net Debt Issued (Repaid)	-602	1,543	748	-2	-2
Issuance of Common Stock	79	73	72	123	129
Repurchase of Common Stock	-495	-175	-303	-1,436	-2,221
Common Dividends Paid	-353	-331	-314	-305	-309
Other Financing Activities	-17	-26	-43	-112	-137
Financing Cash Flow	-1,388	1,084	160	-1,732	-2,540
Foreign Exchange Rate Adjustments	4	-7	-	-	-
Net Cash Flow	-129	-137	371	-557	-286
Free Cash Flow	1,359	909	864	1,314	1,830
Free Cash Flow Growth	49.50%	5.21%	-34.25%	-28.20%	15.31%
Free Cash Flow Margin	12.31%	9.21%	9.34%	13.30%	16.96%
Free Cash Flow Per Share	12.03	8.04	7.65	11.14	14.30
Cash Interest Paid	280	262	134	156	159
Cash Income Tax Paid	169	256	317	283	709
Levered Free Cash Flow	1,257	741	669.75	1,015	1,564
Unlevered Free Cash Flow	1,422	882.25	771.63	1,108	1,659
Change in Working Capital	50	-201	-145	119	87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.